Ashwal S, Russman BS, Blasco PA, et al. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
Cerebral palsy (CP).
Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities website. Available at:
Updated September 7, 2012. Accessed February 1, 2013.
Hazneci B, Tan AK, Guncikan MN, Dincer K, Kalyon TA.
Comparison of the efficacies of botulinum toxin A and Johnstone pressure splints against hip adductor spasticity among patients with cerebral palsy: a randomized trial.
Johnson SL, Blair E, Stanley FJ. Obstetric malpractice litigation and cerebral palsy in term infants.
J Forensic Leg Med
Nolan KW, Cole LL, Liptak GS. Use of botulinum toxin type A in children with cerebral palsy.
Park ES, Park CI, Chang HC, Park CW, Lee DS.
The effect of botulinum toxin type A injection into the gastrocnemius muscle on sit-to-stand transfer in children with spastic diplegic cerebral palsy.
Steinbok P. Selection of treatment modalities in children with spastic cerebral palsy.
10/30/2009 DynaMed's Systematic Literature Surveillance
: Mergler S, Evenhuis HM, Boot AM, et al. Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review.
Dev Med Child Neurol
2/4/2010 DynaMed's Systematic Literature Surveillance
DynaMed's Systematic Literature Surveillance
: Delgado MR, Hirtz D, Aisen M, et al. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.